Natco Pharma Q1 net declines 28% to ₹480 cr on pricing pressure in U.S.
The Hindu
Natco Pharma's Q1 net profit drops 28% due to U.S. market pricing pressure, higher R&D costs, with revenue decline.
More Related News
Natco Pharma's Q1 net profit drops 28% due to U.S. market pricing pressure, higher R&D costs, with revenue decline.